The transcription factor JunD mediates transforming growth factor β-induced fibroblast activation and fibrosis in systemic sclerosis

Inhibition of H3K27 histone trimethylation activates fibroblasts and induces fibrosis
von: Krämer, Marlene, et al.
Veröffentlicht: (2013)

Nintedanib inhibits fibroblast activation and ameliorates fibrosis in preclinical models of systemic sclerosis
von: Huang, Jingang, et al.
Veröffentlicht: (2016)

β-catenin is a central mediator of pro-fibrotic Wnt signaling in systemic sclerosis
von: Beyer, Christian, et al.
Veröffentlicht: (2012)

Blockade of canonical Wnt signalling ameliorates experimental dermal fibrosis
von: Beyer, Christian, et al.
Veröffentlicht: (2013)

Activation of pregnane X receptor inhibits experimental dermal fibrosis
von: Beyer, Christian, et al.
Veröffentlicht: (2013)

Vascular endothelial growth factor aggravates fibrosis and vasculopathy in experimental models of systemic sclerosis
von: Maurer, Britta, et al.
Veröffentlicht: (2014)

Inhibition of Notch1 promotes hedgehog signalling in a HES1-dependent manner in chondrocytes and exacerbates experimental osteoarthritis
von: Lin, Neng-Yu, et al.
Veröffentlicht: (2016)

Combined inhibition of morphogen pathways demonstrates additive antifibrotic effects and improved tolerability
von: Distler, Alfiya, et al.
Veröffentlicht: (2014)

Synthetic cannabinoid ajulemic acid exerts potent antifibrotic effects in experimental models of systemic sclerosis
von: Garcia Gonzalez, Estrella, et al.
Veröffentlicht: (2012)

Type 2 innate lymphoid cell counts are increased in patients with systemic sclerosis and correlate with the extent of fibrosis
von: Wohlfahrt, Thomas, et al.
Veröffentlicht: (2016)

Dysbalance of angiogenic and angiostatic mediators in patients with mixed connective tissue disease
von: Distler, Jörg H. W., et al.
Veröffentlicht: (2011)

Critical role of the adhesion receptor DNAX accessory molecule-1 (DNAM-1) in the development of inflammation-driven dermal fibrosis in a mouse model of systemic sclerosis
von: Avouac, Jérôme, et al.
Veröffentlicht: (2013)

NLRP1 influences the systemic sclerosis phenotype a new clue for the contribution of innate immunity in systemic sclerosis-related fibrosing alveolitis pathogenesis
von: Dieudé, P., et al.
Veröffentlicht: (2011)

Signature of circulating microRNAs in osteoarthritis
von: Beyer, Christian, et al.
Veröffentlicht: (2015)

Molekulare Mechanismen der Fibroblasten-Aktivierung in der Pathogenese der systemischen Sklerose
von: Akhmetshina, Alfiya 1979-
Veröffentlicht: (2009)

Fibroblast growth factors
von: Li, Xiaokun
Veröffentlicht: (2018)

Fibroblast growth factor 1 in multiple sclerosis localization in brain lesions and effects on cultured human astrocytes
von: Friese, Anita Ines
Veröffentlicht: (2014)

TGFβ receptor gene variants in systemic sclerosis-related pulmonary arterial hypertension results from a multicentre EUSTAR study of European Caucasian patients
von: Koumakis, Eugénie, et al.
Veröffentlicht: (2012)

Fibroblast growth factors biology and clinical application, FGF biology and therapeutics
von: Simons, Michael
Veröffentlicht: (2017)

Immunogenetic risk factors of multiple sclerosis
von: Jong, Brigit A. de
Veröffentlicht: (2002)

Aldehyde dehydrogenase family 3 number 2 promotes TGFβ-induced tissue fibrosis in Systemic Sclerosis
von: Xu, Xiaohan
Veröffentlicht: (2022)

Impaired TFAM expression promotes mitochondrial damage to drive fibroblast activation and fibrosis in systemic sclerosis
von: Zhou, Xiang
Veröffentlicht: (2023)

The ETS family transcription factor PU.1 controls fibroblast polarization and tissue fibrosis = <Der ETS-Transkriptionsfaktor PU.1 kontrolliert Fibroblastenpolarisation und Organfibrose
von: Wohlfahrt, Thomas Georg
Veröffentlicht: (2018)

Disease progression in systemic sclerosis-overlap syndrome is significantly different from limited and diffuse cutaneous systemic sclerosis
von: Moinzadeh, Pia 1980-, et al.
Veröffentlicht: (2015)

An open-label study to evaluate biomarkers and safety in systemic sclerosis patients treated with paquinimod
von: Hesselstrand, Roger, et al.
Veröffentlicht: (2021)

The tyrosine phosphatase SHP2 controls TGFβ-induced STAT3 signaling to regulate fibroblast activation and fibrosis
von: Györfi, Andrea-Hermina
Veröffentlicht: (2019)

Downregulation of miR-193b in systemic sclerosis regulates the proliferative vasculopathy by urokinase-type plasminogen activator expression
von: Iwamoto, Naoki, et al.
Veröffentlicht: (2016)

Sociodemographic factors in the epidemiology of multiple sclerosis an annotated bibliography
von: Lowis, George W.
Veröffentlicht: (1991)

Dynamic changes in O-GlcNAcylation regulate osteoclast differentiation and bone loss via nucleoporin 153
von: Li, Yi-Nan, et al.
Veröffentlicht: (2023)

Signal transduction by epidermal growth factor (EGF) and fibroblast growth factor (FGF) receptors role of protein tyrosine phosphorylation
von: Mohammadi, Moosa
Veröffentlicht: (1993)

Reconstruction of the miR-506-Quaking axis in Idiopathic Pulmonary Fibrosis using integrative multi-source bioinformatics
von: Stojanović, Stevan D., et al.
Veröffentlicht: (2021)

Pigment epithelium-derived factor increases neuropathy and fibrosis in pancreatic cancer
von: Samkharadze, Tamar
Veröffentlicht: (2012)

Non-canonical WNT5A promotes tissue fibrosis by JNK-dependent activation of latent TGF-β in Systemic Sclerosis = WNT5A induziert über eine JNK-abhängige Aktivierung von latentem TGF-β Fibrose
von: Chen, Chih-Wei 1984-
Veröffentlicht: (2017)

Platelet-derived growth factor receptor β activation and regulation in primary myelofibrosis
von: Kramer, Frederike
Veröffentlicht: (2019)

Platelet-derived growth factor receptor β activation and regulation in primary myelofibrosis
von: Kramer, Frederike
Veröffentlicht: (2019)

Die Bedeutung des basic fibroblast growth factors bei der renalen Fibrogenese
von: Zeisberg, Michael 1971-
Veröffentlicht: (2000)